MARKET

NTRB

NTRB

Nutriband Inc
NASDAQ
2.750
-0.050
-1.79%
After Hours: 2.640 -0.11 -4.00% 19:11 06/06 EDT
OPEN
2.795
PREV CLOSE
2.800
HIGH
2.795
LOW
2.750
VOLUME
6.54K
TURNOVER
0
52 WEEK HIGH
6.98
52 WEEK LOW
2.409
MARKET CAP
21.54M
P/E (TTM)
-5.1887
1D
5D
1M
3M
1Y
5Y
HOV, LTRX and ELDN among mid-day movers
Seeking Alpha · 6d ago
Nutriband Earnings Perspective: Return On Capital Employed
Benzinga · 05/04 14:51
Nutriband Inc. Reports Revenue Up 46% In Fiscal 2023; FY23 Revenue $2.08M Vs $1.4M YoY; EPS $(0.53) Vs $(0.80) YoY
Benzinga · 04/27 12:13
Pre-market Movers: VKTX, IMRX, OSCR, WISA, ITCI…
NASDAQ · 03/28 12:21
Nutriband Secured $2M Line of Credit Financing Facility to be Used for Commercialization of AVERSA(TM) Abuse-Deterrent Transdermal Technology
Benzinga · 03/28 11:47
BHC, ONVO and AMAM among healthcare gainers
Seeking Alpha · 02/15 16:09
Nutriband To File for Product Distribution Permit In South America With Ecuador's Health Register
Benzinga · 02/15 11:05
Nutriband to Begin Trading on Upstream App
Nutriband to Begin Trading on Upstream App
MT Newswires · 01/05 06:55
More
About NTRB
Nutriband Inc. is engaged in the development of a portfolio of transdermal pharmaceutical products. The Company's lead product is its AVERSA technology, an abuse deterrent technology that can be incorporated into any transdermal patch to deter the abuse, misuse, diversion, and accidental exposure of drugs with abuse potential. Its first product under development is AVERSA Fentanyl, an abuse deterrent fentanyl transdermal system that combines an existing generic fentanyl patch with its AVERSA technology to reduce the abuse and misuse of fentanyl patches. It is also focused on the development of additional products utilizing the AVERSA abuse deterrent transdermal technology, which include AVERSA Buprenorphine and AVERSA Methylphenidate. In addition, it is developing a portfolio of transdermal pharmaceutical products to deliver commercially available drugs or biologics that are typically delivered by injection. Its subsidiaries include 4P Therapeutics LLC and Pocono Pharmaceuticals Inc.

Webull offers kinds of Nutriband Inc stock information, including NASDAQ:NTRB real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, NTRB stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading NTRB stock methods without spending real money on the virtual paper trading platform.